Loading…
Underlying
Underlying Price
$39.57
Type
Call
Strike
45
Expiration
Feb 19, 2027
DTE
135d
Moneyness
OTM
Intrinsic
$0.00
EWTX 45 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 16, 2026 | 9d | $1.00 | -9.09% | 12 | 105 |
| Nov 20, 2026 | 44d | $2.10 | +13.51% | 1 | 80 |
| Dec 18, 2026 | 72d | $4.35 | -23.68% | 1 | 2 |
| Jan 15, 2027 | 100d | — | — | 0 | 0 |
| Feb 19, 2027 | 135d | — | — | 0 | 0 |
| Mar 19, 2027 | 163d | $8.57 | +60.19% | 1 | 2 |
| May 21, 2027 | 226d | $7.00 | +0.00% | 3 | 3 |
EWTX Profile
edgewise therapeutics is a biotechnology company focused on developing novel therapies for diseases involving skeletal muscle. the company is headquartered in boulder, co and received its series a financing from orbimed.